Plasma ghrelin concentrations are lower in binge-eating disorder.
Binge-eating disorder (BED), characterized by binge meals without purging afterward, is found in about 30% of obese individuals seeking treatment. The study objective was to ascertain abnormalities in hormones influencing appetite in BED, especially ghrelin, an appetite-stimulating peptide, which was expected to be elevated. Measurements were made of plasma insulin, leptin, glucagon, cholecystokinin, and ghrelin, as well as glucose following an overnight 12-h fast, prior to and after ingestion (from 0 to 5 min) of a nutritionally complete liquid meal (1254 kJ) at 0830 h, at -15, 0, 5, 15, 30, 60, 90, and 120 min. Appetite ratings including hunger and fullness were also obtained. An acetaminophen tracer was used to assess gastric emptying rate. Three groups of comparably obese women (BMI = 35.9 +/- 5.5; % body fat = 44.9 +/- 4.7) participated: 12 nonbinge eating normals (NB), 14 subthreshold BED, and 11 BED. The BED subjects, compared to NB subjects, had lower baseline ghrelin concentrations prior to the meal, a lower area under the curve (AUC), with lower levels at 5, 15, 30, 90, and 120 min, and a smaller decline in ghrelin postmeal (all P < 0.03). The other blood values did not differ among groups, and neither did gastric emptying rate nor ratings of fullness. The BED subjects were then randomly assigned to treatment with cognitive-behavior therapy and diet (n = 5) or to a wait-list control (n = 4). Baseline ghrelin (P = 0.01) and AUC increased (P = 0.02), across both conditions, in which most subjects (7 of 9) stopped binge eating. The lower fasting and postmeal plasma ghrelin levels in BED are consistent with lower ghrelin levels in obese compared to lean individuals and suggests downregulation by binge eating.
Geliebter
Allan
A
Department of Medicine, New York Obesity Research Center, St. Luke's Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY, USA. ag58@columbia.edu
Gluck
Marci E
ME
Hashim
Sami A
SA
D000328:Adult; D001066:Appetite / Q000502:physiology; D019540:Area Under Curve; D001786:Blood Glucose / Q000378:metabolism; D015992:Body Mass Index; D002032:Bulimia / Q000097:blood* / Q000628:therapy; D002766:Cholecystokinin / Q000097:blood; D015928:Cognitive Behavioral Therapy; D004032:Diet; D005260:Female; D054439:Ghrelin; D006801:Humans; D020738:Leptin / Q000097:blood; D009765:Obesity / Q000097:blood; D036361:Peptide Hormones / Q000097:blood*; D019518:Postprandial Period; D017697:Premenopause; D012016:Reference Values
D001786:Blood Glucose; D054439:Ghrelin; D020738:Leptin; D036361:Peptide Hormones; D002766:Cholecystokinin